Skip to content
Business

Microsoft's Azure Grows 48% as Cash Spending on Equipment Doubles to $39bn

Microsoft's revenue rose 19% to $92.3bn in its fiscal first quarter as Azure grew 48%, while cash spent on property and equipment doubled to $39.4bn as the AI build-out continued.

Aerial view of Microsoft's Fairwater AI datacenter campus in Wisconsin under construction, with banks of cooling units (1080x720, checked)
Photo: Microsoft

Microsoft said its fiscal first-quarter results exceeded expectations, with revenue up 19% to $92.3bn and its Azure cloud platform growing 48%. The price of that growth showed up in the cash flow statement: additions to property and equipment, mostly data centres and chips, doubled to $39.4bn from $19.4bn a year earlier.

The results for July to September came after the close on Wall Street on 28 October. Finance chief Amy Hood was blunt about the quarter: "Results exceeded expectations across revenue, operating income, and earnings per share."

Microsoft, July to September

  • $92.3bn revenue, up 19%
  • +48% Azure revenue growth
  • $39.4bn additions to property and equipment

Cloud does the heavy lifting

Microsoft Cloud revenue rose 30% to $63.9bn, or 31% at constant currency, and now accounts for more than two-thirds of group sales. Within it, Azure's 48% growth was the standout. Microsoft 365 commercial cloud revenue grew 17%.

The company reports under a new structure, recast in September 2026, with two segments. The larger one did all the growing.

SegmentRevenueGrowthOperating income
Agents and Infra$76.8bn+25%$40.6bn
Devices and Consumer$15.5bn-3%$5.4bn
Group$92.3bn+19%$45.9bn

Devices and Consumer slipped as Windows sales to PC makers and device revenue fell 22% and Xbox content and services dipped 2%. Search and advertising revenue, excluding traffic acquisition costs, grew 12%.

Group operating income rose 21% to $45.9bn. Net income jumped 32% to $36.6bn, or $4.92 a share. Stripping out the effect of Microsoft's investment in OpenAI, which added a $207m gain this quarter against a $3.1bn loss a year earlier, net income rose 18% to $36.4bn, or $4.89 a share.

Rows of server racks with yellow cabling inside a Microsoft AI datacenter (1080x539, checked).
Rows of server racks with yellow cabling inside a Microsoft AI datacenter (1080x539, checked). Photo: Microsoft

Microsoft: share price, chart and news

The spending question

The bill for the AI build-out keeps rising. Cash additions to property and equipment of $39.4bn compare with $19.4bn a year earlier, an increase of about 103%. Revenue grew $14.6bn over the same period, from $77.7bn a year earlier, so spending is rising much faster than sales. Cash spent on property and equipment equalled about 43% of revenue in the quarter, against roughly 25% a year earlier.

Microsoft argues the demand is already contracted. Its commercial remaining performance obligation, the value of signed contracts not yet billed, rose 73% to $677bn. That backlog is the main reason investors have tolerated the capital spending so far.

What stood out

  • Azure revenue grew 48%, and Microsoft Cloud revenue 30% to $63.9bn
  • Commercial remaining performance obligation rose 73% to $677bn
  • Spending on property and equipment doubled year on year to $39.4bn
  • OpenAI investments added a $207m gain, after a $3.1bn loss a year earlier

How the shares came into the results

Microsoft's shares have been steady rather than spectacular this autumn. The stock closed last week at $524.51, down 0.9% on the week and about 2% above where it ended August. The Nasdaq 100 was down about 1.6% over the same stretch.

The debate around the stock is less about demand than about cost. The same question hangs over Microsoft's big cloud rivals, Amazon and Alphabet, which are also spending heavily on AI capacity.

What comes next

Microsoft does not put its outlook in the press release. Management was due to give guidance for the December quarter, including Azure growth and capital spending, on its call with analysts later on Wednesday evening, European time.

Three numbers will matter most when it does: how fast Azure is expected to grow, how much more capital spending is planned, and whether Microsoft still says demand is running ahead of the capacity it can bring online. For a company of Microsoft's size, the gap between cloud growth and spending growth is now the number investors watch.

Sources

Related stories

Markets

AI Chip Rout Drags the Nasdaq Into Correction, Wiping Out the Post-Election Rally

The Nasdaq fell 5.52 percent on Thursday, its worst day since April 2025, as chipmakers collapsed and the largest US tech groups lost about $900 billion in value.

Business

Amazon's AWS Grows 39%, Its Fastest in Nearly Five Years, as Free Cash Flow Turns Negative

AWS revenue rose 39% to $46bn, its fastest growth in nearly five years, but Amazon's $1.89 earnings per share missed forecasts and trailing free cash flow swung to minus $42.4bn.

Investing

Anthropic Sets Terms for a $61bn Nasdaq IPO at a $1.2 Trillion Valuation

Anthropic set a $70 to $78 range for its Nasdaq listing, aiming to raise $61bn at a $1.2 trillion valuation, with Nvidia, AMD, TSMC and others buying $26bn more in a private…

Investing

AI Trade Carries the Nasdaq to Records Even With Treasury Yields Above 5%

The Nasdaq set a record close of 27,244.28 and gained 2.1 percent on the week as AMD, Microsoft and Akamai rallied on AI news, even with the US 10-year Treasury yield above 5…

Business

Québecor Makes a C$31bn Cash-and-Share Bid for Telus, Which Warns of Regulatory Risk

Québecor has offered C$6.35 in cash plus 0.17 of its own shares for each Telus share, a bid worth about C$31bn. The Telus board says the price falls short and the regulatory risk…

Business

Tyson Foods Shares Jump 8.7% as Beef Outlook Outweighs a $74m Quarterly Loss

Tyson Foods posted a $74m fourth-quarter net loss and adjusted EPS of $0.61, down 47%, yet its shares closed 8.7% higher on Monday as its 2027 beef outlook pointed to far smaller…

Business

Roche Wins FDA Approval for Breast Cancer Pill Wilserdly After 62% Cut in Progression Risk

The FDA approved Roche's all-pill Wilserdly combination for ESR1-mutated advanced breast cancer after it cut the risk of progression or death by 62%. A ruling on early-stage use is…

Business

ULA Loses Its First Mission as Vulcan Rocket Fails With 40 Amazon Leo Satellites on Board

United Launch Alliance's Vulcan rocket failed about 10 minutes after lift-off on Sunday, and all 40 Amazon Leo satellites were lost. Amazon fell 3.3% on Monday as space stocks…